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Abstract
Purpose: The aim of this study was to investigate the pathway to amplification technologies for children who passed their
universal newborn hearing screening (UNHS) bilaterally with the intent of revealing effective strategies to identify children
with acquired or progressive hearing losses. Additionally, the degrees, types, and causes of hearing loss, as well as the
types of amplification used by the patients were investigated.
Methodology: Medical records were reviewed for 102 children who passed their UNHS bilaterally and who are enrolled in
the Boston Children’s Hospital Amplification or Cochlear Implant Programs. Of the 204 total ears, 177 ears were identified
with hearing loss and were included in the study.
Conclusion: More than half of new hearing loss identifications in children over 11 years and approximately one third of
all new hearing loss identifications resulted from a referred hearing screening. For children under age three, a speechlanguage delay was the most common reason for referral leading to identification of a permanent, postnatal hearing loss.
This study emphasizes the importance of routine hearing screenings in school-aged children as well as highlights the
need for audiological evaluations when signs of childhood hearing loss arise, such as a speech-language delay.
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Universal Newborn Hearing Screening (UNHS) has
remarkable value in decreasing the average age of hearing
loss identification (Dalzell et al., 2000; Vohr et al., 1998);
however, it is possible for a child to pass the newborn
hearing screening with a mild, congenital hearing loss.
Current automated auditory brainstem response (AABR)
testing and otoacoustic emissions (OAEs) screening tools
frequently use a 30–35 dB criterion level, which would
fail to capture newborns with a slight to mild hearing loss.
Johnson et al. (2005) estimates that approximately 23% of
newborns who have a permanent hearing loss would pass
a UNHS conducted via AABR as a result of the chosen
screening level.
In addition, there are many causes of delayed-onset
congenital or acquired hearing loss that can occur in
childhood, including hearing loss associated with genetic
mutations, infectious diseases, anatomic abnormalities,

trauma, and ototoxicity (Kenna, 2015). By age nine, 25%
of permanent childhood hearing loss is postnatal in nature,
suggesting that while the UNHS is playing a significant role
in the identification of permanent childhood hearing loss,
provisions must also be in place to identify children who
acquire hearing loss postnatally (Weichbold et al., 2006;
Watkin & Baldwin, 2011). Among the cases of permanent
childhood hearing loss identified through post-neonatal
care pathways, hearing loss is most commonly identified
due to school hearing screenings and parental concerns
regarding hearing (Dedhia et al., 2013; Watkin & Baldwin,
2011). Once identified, Walker et al. (2014) observed
significantly longer delays from hearing loss identification
to intervention for children with postnatal hearing loss
compared to children who were identified in the newborn
period. The same investigation revealed that degree of
hearing loss predicted age at follow-up clinical services
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for children with postnatally identified hearing loss, such
that children with more severe losses received services
at younger ages compared to children with milder hearing
loss.
Approximately 40% of patients in the Amplification
Program at Boston Children’s Hospital (BCH) passed their
UNHS bilaterally. In the BCH Cochlear Implant Program,
18% of patients with known UNHS outcomes passed
in both ears. We designed this study to investigate the
pathway to amplification technologies for children who
passed their UNHS with the aim of revealing the factors
that led to the later identification of children with hearing
loss. This study addresses the average age of hearing loss
identification and the average time between hearing loss
identification and amplification fittings in this population.
Additionally, we describe the degree, type, and causes
of hearing loss observed. Based on previous studies
described above, we hypothesized that most children
would be identified through childhood hearing screening
programs and that more severe hearing losses would have
a shorter time between identification and intervention.
Methods
We reviewed medical records of 102 children who passed
their UNHS and who are enrolled in the BCH Amplification
and/or Cochlear Implant Programs. Medical records were

included for review from July 1999 through July 2018.
Participants were included in this study if they were (a)
identified with hearing loss between 0–22 years of age, (b)
had known outcomes of their UNHS, and (c) were users of
amplification technologies including hearing aids, cochlear
implants, or bone anchored hearing systems. Of the 204
ears, 177 ears were identified with permanent hearing
loss and were included in the study. Table 1 indicates
the breakdown of participants by sex and by whether the
hearing loss was unilateral or bilateral at initial diagnosis.
Table 1
Participant Breakdown by Sex and Number of Ears with
Hearing Loss (Unilateral vs. Bilateral)

Male

Female

Total

Bilateral

37 (36.3%)

38 (37.3%)

75 (73.5%)

Unilateral

16 (15.7%)

11 (10.8%)

27 (26.5%)

Total

53 (52.0%)

49 (48.0%)

102 (100%)

Figures 1 and 2 respectively display the age of
identification broken down by laterality of hearing loss and
by sex. Note that race/ethnicity data are not reliably coded
in the hospital medical record and are not included.

Figure 1
Histogram of Age (in Years) of Identification of Hearing Loss Split by Unilateral Versus Bilateral Hearing Loss
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Note. Age of identification was not significantly different between these two groups (t78 = -0.6, p = 0.5).
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Figure 2
Histogram of Age (in years) of Identification of Hearing Loss Split by Sex of Participant
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Note. Age of identification was not significantly different between these two groups (t98 = -0.08, p = 0.9).
When reviewing the medical records, we investigated
certain criteria to describe the type, degree, and
configuration of the hearing losses. The types of hearing
loss were determined to be sensorineural, conductive,
or mixed. We categorized the patients’ hearing loss
configurations using the terms flat, rising, sloping, cookie
bite, reverse cookie bite, notched, or unconventional.
The patients’ best threshold degrees and worst threshold
degrees were documented to fully capture their hearing
loss and to not exclude those with irregular configurations.
Additionally, the patients’ 2000 Hz pure tone threshold
degrees were documented due to the importance of 2000
Hz in speech recognition.
To capture the patients’ timeline to amplification
technologies, we looked at the month and year of initial
hearing loss diagnosis and calculated the years between
birth and hearing loss identification to find the average
age of identification. We then investigated the month and
year of initial hearing aid fitting and calculated the years
between hearing loss identification and hearing aid fitting.
For patients who use cochlear implants, we documented
the date of initiation for their pre-surgical hearing aid trial,
if known; if there was no documented hearing aid trial, the
date of intervention was marked as the implant surgery
date. With this information we were able to calculate
the average amount of time between initial hearing loss
diagnosis and amplification fitting across all of our patients.

We were also interested in capturing identifiable reasons
for the referral for audiological evaluations. These fields
included a referred hearing screening at the pediatrician
or school, speech-language delay, pediatrician concern,
parental concern, suspected or confirmed diagnosis of
autism spectrum disorder, or other medical referral from
a specialist. These reasons were not mutually exclusive,
and, for some patients, more than one reason was
selected. In our records, it was not always clear whether
the hearing screening was performed at the doctor’s
office or the school; hence these are combined. Tier 1
and 2 risk factors for childhood hearing loss outlined by
the Massachusetts Department of Public Health (Table
2) were investigated as possible predictors for late-onset
childhood hearing loss. The risk factor tier indicates when
an infant would receive follow-up hearing testing. Infants
born with Tier 1 risk factors are recommended to receive
a diagnostic ABR by 3 months of age. This appointment is
scheduled by the birth hospital prior to discharge. Infants
born with Tier 2 risk factors are recommended to receive
a diagnostic hearing assessment at 6–9 months of age
(Stewart, 2017). This is coordinated by the medical home.
Knowing the etiology of hearing loss was important in
the determination of whether the participant’s hearing
loss was acquired, presumably congenital missed by
the UNHS, or delayed-onset congenital. If the etiology
of the hearing loss was known, we categorized them as
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Table 2
Massachusetts Department of Public Health Tier 1 and Tier 2 Risk Factors for Hearing Loss
Tier 1

Tier 2

• Maternal CMV

• > 10 days mechanical ventilation

• Down Syndrome

• ≤ 32 weeks gestational age

• Cleft lip/palate

• < 1500 grams birth weight

• Bacterial meningitis

• Permanent hearing loss in extended family

• Craniofacial anomalies

• Herpes, rubella, syphilis, or toxoplasmosis

• Syndromes associated with hearing loss

• Head trauma

• Perinatal asphyxia

• Ear pits with preauricular tags

• ECMO

• Ototoxic medications (> 7 day course in
conjunction with loop diuretics)

• Hyperbilirubinemia (> 20 mg/dL bilirubin)
• Permanent hearing loss in immediate
family

• NICU stay > 5 days

• Parental or medical provider concern
Note. CMV = cytomegalovirus, ECMO = Extracorporeal membrane oxygenation, NICU = Newborn Intensive Care Unit.
genetic, such as connexin-26 or related with a syndrome;
anatomical, such as enlarged vestibular aqueduct (EVA);
caused by infection, such as cytomegalovirus (CMV);
caused by ototoxic medications, such as chemotherapy;
or due to another cause. We further wanted to investigate
whether the patients had a coexisting diagnosis related to
neurologic status, such as Autism Spectrum Disorder or
intellectual disability.
Results
Approximately half (52.0%) of hearing losses were
sensorineural in nature. Conductive hearing loss
comprised 30.5% of hearing losses in our cohort and the
remaining 17.5% of hearing losses were mixed in nature.
Figure 3 illustrates degree of hearing loss for the 177 ears
in the study based on the 2000 Hz threshold, the best
threshold, and the poorest threshold. For 63.8% of ears,
the 2000 Hz threshold at hearing loss identification was
in the normal hearing or mild hearing loss range. 2000 Hz
thresholds were observed in the moderate or moderatelysevere hearing loss range for 26.0% of ears and in the
severe to profound range for the remaining 10.1% of ears.
At initial identification, more than 80% of ears had at least
one pure-tone threshold in the normal to mild loss range
and more than 60% of ears had at least one pure-tone
threshold in the moderate to profound range. The majority
(90.2%) of participants wore hearing aids; 8.8% used
cochlear implants exclusively or as a bimodal solution. The
rest of the participants (1%) used a bone-anchored device.
Etiologies of hearing loss varied greatly across
participants. Unknown etiology accounted for 37.3%
of participants, often despite the use of temporal bone
imaging and genetic testing under management by an
otolaryngologist. Acquired conditions accounted for

31.4% of hearing loss, including conditions such as
chronic otitis media (53.1%), cholesteatoma (25.0%), or
ototoxicity (18.8%). Syndrome related losses accounted
for 16.7% of participants, of which the most common was
Down syndrome (58.8%). Enlarged vestibular aqueducts
accounted for 10.8% of participants. Connexin-26 genetic
mutations accounted for 3.9% of participants. Congenital
CMV (cCMV) accounted for 2.9% of participants.
Incidentally, 5.9% of participants had a comorbid diagnosis
of Autism Spectrum Disorder and 4.9% of participants had
a comorbid diagnosis of intellectual disability.
Table 2 summarizes hearing loss identification and
amplification fitting timelines by type of hearing loss. The
average age of hearing loss identification was 5.7 years
(SD = 3.6 years). Group means for type of hearing loss
were evaluated for differences using one-way Analysis
of Variance (ANOVA) testing. No significant difference
for age of hearing loss identification was observed
based on hearing loss type, F(2, 174) = 2.79, p = 0.06.
Once identified with hearing loss, the average time from
diagnosis to amplification fitting was 2.0 years (SD = 2.8
years). A significant main effect of type of hearing loss
was observed for the time from hearing loss diagnosis to
amplification fitting, F(2, 174) = 6.45, p < 0.01. A Tukey
test for multiple comparison of means, using a 99%
confidence level, revealed that children with sensorineural
hearing loss had a significantly shorter time from hearing
loss diagnosis to amplification fitting than children with
conductive hearing loss (p < 0.01). No difference was
observed when comparing children with mixed hearing
loss to those with either sensorineural (p = 0.15) or
conductive hearing losses (p = 0.63).
Tier 1 and 2 risk factors for hearing loss were investigated
as possible predictors for late-onset childhood hearing
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loss. At least one Tier 1 or 2 risk factor for hearing loss in
the neonatal period was present for 40.2% of our cohort.
The average age of hearing loss identification for those
with at least one risk factor was 5.6 years (SD = 4.2 years)
compared to 5.8 years (SD = 2.8 years) for those without a
risk factor. A Tier 1 risk factor for hearing loss was present
in 24.5% of participants. The most frequent Tier 1 risk
factor was an immediate family history of hearing loss
(n = 9) followed by cCMV (n = 3). 19.6% of participants
had a Tier 2 risk factor for hearing loss. Among Tier 2 risk
factors, the most commonly observed was a neonatal
intensive care unit stay of greater than 5 days (n = 11). Six
participants had an extended family history of hearing loss.

Five participants were given ototoxic medication in the
neonatal period. Five participants had a gestational age of
less than 32 weeks.
Table 3 shows reasons for audiological referral by age
group. Approximately 1 in 4 patients did not have an
identifiable reason for audiological evaluation. For children
older than 3, a hearing screening was the primary reason
for referral for diagnostic hearing testing. For children
under age three, a speech-language delay was the most
common reason for referral leading to identification of
a permanent, postnatal hearing loss. A referral from a
specialist (e.g., geneticist, developmental pediatrician,
cardiologist) led to diagnosis for 22.1% of patients.

Table 3
Reason for Referral for Audiological Evaluation by Age Group (Age of Diagnosis)
Infant/Toddler
(0-3 Years)

Preschool
(4-5 Years)

Early School
(6-10 Years)

Later School
(11+ Years)

All Ages

25

31

39

7

102

0.0%

38.1%

35.5%

57.1%

27.5%

SpeechLanguage Delay

37.9%

22.9%

16.1%

14.3%

25.5%

Referral from
Specialist

27.6%

17.1%

22.6%

0.0%

20.6%

Parent Concern

17.2%

22.9%

9.7%

14.3%

16.7%

Primary Care
Provider Referral

0.0%

5.7%

6.5%

14.3%

4.9%

34.5%

14.3%

25.8%

14.3%

23.5%

n
Referred
Screening

No Known
Reason

ANOVA was performed to determine whether severity
of hearing loss was related to identification of hearing
loss. The analysis indicated no significant relationship
between severity of hearing loss, either based on best
hearing threshold or best threshold at 2 kHz, and number
of months between identification of hearing loss and
first fitting with amplification. The average time between
identification and fitting was 25.5 months (SD = 34.9
months).
Discussion
The implementation of the UNHS has made a significant
impact on early hearing detection and intervention.
However, UNHS cannot stand alone in detection of
childhood hearing loss. As observed by Walker et al.
(2014), this study indicates that children identified with
hearing loss through post-natal pathways experience
long delays between hearing loss identification and the
implementation of hearing loss interventions.
Documented risk factors for hearing loss fall into two tiers,
which then determines the timeline for initial diagnostic
testing. Children with a Tier 1 or Tier 2 risk factor requiring
diagnostic testing may have not developed hearing loss

by the time of initial appointment despite the possibility of
later-onset hearing loss. This supports routine monitoring
and screening of hearing to document any changes in a
prompt manner. However, the risk factors do not capture
every child who may develop a delayed-onset congenital
or acquired hearing loss. The list of risk factors increases
the number of children being diagnostically monitored for
potential hearing loss in childhood but cannot encompass
or predict all children that will require audiological
evaluations. This is supported by our cohort as children
with and without risk factors were included.
Children who pass their UNHS, but experience signs
of hearing loss during childhood must be appropriately
referred to an audiologist trained to evaluate hearing
in pediatric patients. The most frequent catalyst for
hearing loss identification in our cohort was referring on a
routine hearing screening, consistent with published data
(Dedhia et al., 2013; Watkin & Baldwin, 2011). Our data
demonstrate the importance and necessity of school- and
primary care provider-based hearing screenings in the
process of identifying and treating children with hearing
loss. There may have been delays that we could not
capture in this study. For instance, if a patient referred their
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school screening and then went to their physician for a
repeat screening and then was referred to our clinic, this
may have caused added delay to the time of diagnosis.
Additionally, our data show the importance of referring
children with speech delays for hearing evaluations, even
if they passed the newborn hearing screening. This was
the primary route to identification for children under 3
years of age. Speech-language pathologists and Early
Intervention staff should not assume hearing is normal if a
child passed their newborn hearing screening and should
include a hearing test as part of the work-up when a child
is exhibiting speech and language delays.
We found that the average duration between diagnosis
and fitting is greater than one year. This suggests there
is a lesser sense of urgency for these older children than
there is for children who refer newborn hearing screening
and are fit with amplification by 6 months. Boston
Children’s Hospital does abide by the EHDI 1-3-6 guideline
for newborns, it being tied to a state mandate. These
data suggest that Boston Children’s may benefit from an
initiative to fit later-diagnosed children with hearing aids
within 3 months of diagnosis.
Our data also demonstrate a relative greater average time
from diagnosis to fitting of children with conductive hearing
losses. This is not surprising given the time it takes to
evaluate candidacy for the greater number of medical and
surgical treatments available for conductive hearing loss.
Future research may evaluate whether efforts to quickly
determine the etiology of conductive hearing loss may
lead to earlier fitting of amplification. Future research may
evaluate whether there are benefits to fitting amplification
synchronously with the medical evaluation process instead
of waiting for the physicians to complete their assessments
prior to fitting amplification. This finding raises the question
as to whether the addition of new options for medically
treating sensorineural hearing loss (e.g., gene therapy)
may increase time between diagnosis and fitting in the
coming years.
Conclusions
It is critical to reinforce the importance of regular childhood
hearing screenings through later school-age years. These
efforts provide opportunities for earlier identification of
childhood hearing loss allowing for earlier intervention
options. Family members, educational professionals and
clinicians alike should be aware of and pay attention to
signs of childhood hearing loss, such as speech-language
delay, academic difficulties, and increased exhaustion at
the end of a school day to ensure proper referrals lead to
early diagnosis. Pediatric medical centers should ensure
that, once diagnosed with hearing loss, older children are
being fit with amplification with as little delay as possible,
similar to the 1-3-6 guidelines for newborns.
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